EYENOVA EYE MEDICAL LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Aug 2026, 22:41 | Notification of cessation of securities - EYE | Other | — | 06027 | |
| 29 July 2026, 21:10 | Investor Webinar Tuesday 4 August 2026 @ 11.30 AEST | Presentations | — | 14014 | |
| 29 July 2026, 21:03 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 11 July 2026, 00:39 | Application for quotation of securities - EYE | Other | — | 06020 | |
| 26 June 2026, 00:55 | Notification of cessation of securities - EYE | Other | — | 06027 | |
| 26 June 2026, 00:49 | Notification of cessation of securities - EYE | Other | — | 06027 | |
| 7 May 2026, 01:04 | Notification regarding unquoted securities - EYE | Other | — | 06021 | |
| 7 May 2026, 01:02 | Application for quotation of securities - EYE | Other | — | 06020 | |
| 5 May 2026, 19:48 | EYE lifts Sales Guidance | Periodic Reports | MS | 03014 | |
| 5 May 2026, 19:47 | Q3FY26 Investor Presentation May26 | Presentations | — | 03026 | |
| 30 Apr 2026, 20:27 | Investor Webinar Tuesday 5 May @ 11.30 AEST | Presentations | — | 14014 | |
| 29 Apr 2026, 18:26 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 11 Mar 2026, 20:31 | Application for quotation of securities - EYE | Other | — | 06020 | |
| 3 Mar 2026, 20:14 | EYE Receives EU MDR Certification | Company Update | — | 11001 | |
| 26 Feb 2026, 19:23 | Investor Webinar Tuesday 3 March @11.30 AEDT | Presentations | — | 14014 | |
| 26 Feb 2026, 19:16 | Investor Presentation Half Year Results | Financial Results | — | 03004, 03026 | |
| 26 Feb 2026, 19:16 | EYE Delivers Sales Growth and Improves Bottom Line | Financial Results | MS | 03004, 03014 | |
| 26 Feb 2026, 19:15 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 12 Feb 2026, 00:46 | Re-lodgement of Appendix 4G | Company Administration | — | 03025, 12008 | |
| 4 Feb 2026, 22:30 | Peer-Reviewed Real-World Evidence Supports iTrack | Company Administration | — | 12008 | |
| 30 Jan 2026, 02:23 | Investor Webinar Monday 2 February @ 11.30 AEDT | Presentations | — | 12008, 14014 | |
| 29 Jan 2026, 19:44 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 27 Jan 2026, 20:45 | ITrack Registry Clinical Data Update | Company Update | — | 11001 | |
| 19 Jan 2026, 21:24 | Investor Webinar Presentation December 2025 | Presentations | — | 03026 | |
| 15 Jan 2026, 20:09 | Investor Webinar 19 January 2026 | Presentations | — | 14014 | |
| 12 Jan 2026, 20:46 | Record Sales Result December 2025 Quarter | Periodic Reports | MS | 03014 | |
| 5 Dec 2025, 21:34 | Notification regarding unquoted securities - EYE | Other | — | 06021 | |
| 5 Dec 2025, 21:26 | Application for quotation of securities - EYE | Other | — | 06020 | |
| 28 Nov 2025, 00:48 | EYE AGM 2025 Meeting Results | Meetings & Governance | — | 08003 | |
| 27 Nov 2025, 21:30 | AGM 2025 Presentation | Presentations | — | 03026, 15002 | |
| 27 Nov 2025, 21:28 | AGM 2025 Chairmans Address | Letters & Addresses | — | 15002 | |
| 18 Nov 2025, 01:37 | EYE Investor Webinar iTrack in Practice | Company Administration | — | 12008 | |
| 5 Nov 2025, 22:32 | Investor Webinar | Presentations | MS | 03026 | |
| 31 Oct 2025, 19:27 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 31 Oct 2025, 05:26 | Investor Webinar 5 November 2025 @11.30 am AEDT | Presentations | — | 14014 | |
| 29 Oct 2025, 01:45 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 2 Oct 2025, 03:02 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006, 12008 | |
| 30 Sept 2025, 19:24 | iTrack Advance Approved for Sale in China | Company Update | MS | 11001 | |
| 15 Sept 2025, 20:40 | Notification of cessation of securities - EYE | Other | — | 06027 | |
| 15 Sept 2025, 20:38 | Notification regarding unquoted securities - EYE | Other | — | 06021 | |
| 15 Sept 2025, 20:33 | Application for quotation of securities - EYE | Other | — | 06020 | |
| 4 Sept 2025, 20:39 | Appendix 3Y Change in Director's Interest T A Spurling | Director Interests | — | 02009 | |
| 28 Aug 2025, 02:24 | Investor Presentation 30 June 2025 Results | Financial Results | MS | 03003, 03026 | |
| 28 Aug 2025, 02:22 | Appendix 4G and Corporate Governance statement | Company Administration | — | 03024, 03025 | |
| 28 Aug 2025, 02:20 | Full year Financial Results | Financial Results | MS | 03003 | |
| 28 Aug 2025, 02:19 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 6 Aug 2025, 03:23 | Appendix 3Y Spurling | Director Interests | — | 02009 | |
| 4 Aug 2025, 21:49 | Application for quotation of securities - EYE | Other | — | 06020 | |
| 4 Aug 2025, 21:33 | Application for quotation of securities - EYE | Other | — | 06020 |
1–49 of 49
1 / 1